Literature DB >> 11139472

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.

I Fleming1, U R Michaelis, D Bredenkötter, B Fisslthaler, F Dehghani, R P Brandes, R Busse.   

Abstract

In the porcine coronary artery, a cytochrome P450 (CYP) isozyme homologous to CYP 2C8/9 has been identified as an endothelium-derived hyperpolarizing factor (EDHF) synthase. As some CYP enzymes are reported to generate reactive oxygen species (ROS), we hypothesized that the coronary EDHF synthase may modulate vascular homeostasis by the simultaneous production of ROS and epoxyeicosatrienoic acids. In bradykinin-stimulated coronary arteries, antisense oligonucleotides against CYP 2C almost abolished EDHF-mediated responses but potentiated nitric oxide (NO)-mediated relaxation. The selective CYP 2C9 inhibitor sulfaphenazole and the superoxide anion (O(2-)) scavengers Tiron and nordihydroguaretic acid also induced a leftward shift in the NO-mediated concentration-relaxation curve to bradykinin. CYP activity and O(2-) production, determined in microsomes prepared from cells overexpressing CYP 2C9, were almost completely inhibited by sulfaphenazole. Sulfaphenazole did not alter the activity of either CYP 2C8, the leukocyte NADPH oxidase, or xanthine oxidase. ROS generation in coronary artery rings, visualized using either ethidium or dichlorofluorescein fluorescence, was detected under basal conditions. The endothelial signal was attenuated by CYP 2C antisense treatment as well as by sulfaphenazole. In isolated coronary endothelial cells, bradykinin elicited a sulfaphenazole-sensitive increase in ROS production. Although 11,12 epoxyeicosatrienoic acid attenuated the activity of nuclear factor-kappaB in cultured human endothelial cells, nuclear factor-kappaB activity was enhanced after the induction or overexpression of CYP 2C9, as was the expression of vascular cell adhesion molecule-1. These results suggest that a CYP isozyme homologous to CYP 2C9 is a physiologically relevant generator of ROS in coronary endothelial cells and modulates both vascular tone and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139472     DOI: 10.1161/01.res.88.1.44

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  100 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 2.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

3.  Reduced flow-and acetylcholine-induced dilations in visceral compared to subcutaneous adipose arterioles in human morbid obesity.

Authors:  Ivana Grizelj; Ana Cavka; Jing-Tan Bian; Mary Szczurek; Austin Robinson; Shruti Shinde; Van Nguyen; Carol Braunschweig; Edward Wang; Ines Drenjancevic; Shane A Phillips
Journal:  Microcirculation       Date:  2015-01       Impact factor: 2.628

4.  Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.

Authors:  Tracy C Delozier; Grace E Kissling; Sherry J Coulter; Diana Dai; Julie F Foley; J Alyce Bradbury; Elizabeth Murphy; Charles Steenbergen; Darryl C Zeldin; Joyce A Goldstein
Journal:  Drug Metab Dispos       Date:  2007-01-12       Impact factor: 3.922

5.  Age-related impairment of conducted dilation in human coronary arterioles.

Authors:  Attila Feher; Zuzana Broskova; Zsolt Bagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

6.  Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery.

Authors:  Anthie Ellis; Malarvannan Pannirselvam; Todd J Anderson; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

7.  Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.

Authors:  Kimberly L Fife; Yingmei Liu; Kara R Schmelzer; Hsing-Ju Tsai; In-Hae Kim; Christophe Morisseau; Bruce D Hammock; Deanna L Kroetz
Journal:  J Pharmacol Exp Ther       Date:  2008-09-24       Impact factor: 4.030

8.  Cytochrome P-450 2C9 signaling does not contribute to age-associated vascular endothelial dysfunction in humans.

Authors:  Anthony J Donato; Iratxe Eskurza; Kristen L Jablonski; Lindsey B Gano; Gary L Pierce; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2008-07-31

9.  Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

Authors:  Jeffrey J Iliff; Nabil J Alkayed
Journal:  Future Neurol       Date:  2009-03-01

10.  Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.

Authors:  Mahmood Khan; Iyyapu K Mohan; Vijay K Kutala; Sainath R Kotha; Narasimham L Parinandi; Robert L Hamlin; Periannan Kuppusamy
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.